All Relations between Alzheimer Disease and matrix compartment

Reference Sentence Publish Date Extraction Date Species
Miren Revuelta, Janire Urrutia, Alvaro Villarroel, Oscar Casi. Microglia-Mediated Inflammation and Neural Stem Cell Differentiation in Alzheimer's Disease: Possible Therapeutic Role of K Frontiers in cellular neuroscience vol 16 issue 2022 35530176 microglia-mediated inflammation and neural stem cell differentiation in alzheimer's disease: possible therapeutic role of k increase of deposits of amyloid \xce\xb2 peptides in the extracellular matrix is landmark during alzheimer's disease (ad) due to the imbalance in the production vs. clearance. 2022-05-09 2022-05-12 Not clear
Haijing Sun, Anna Wang, Shanshan H. Temporal and Spatial Analysis of Alzheimer's Disease Based on an Improved Convolutional Neural Network and a Resting-State FMRI Brain Functional Network. International journal of environmental research and public health vol 19 issue 8 2022 35457373 firstly, multi-time resting-state fmri images were obtained from the alzheimer's disease neuroimaging initiative (adni) database for preprocessing, and then an aal brain partition template was used to construct a 90 \xc3\x97 90 functional connectivity (fc) network matrix of a whole-brain region of interest (roi). 2022-04-23 2022-04-25 Not clear
Dominika Pilat, Jean-Michel Paumier, Laura Garc\\xc3\\xada-Gonz\\xc3\\xa1lez, Laurence Louis, Delphine Stephan, Christine Manrique, Michel Khrestchatisky, Eric Di Pasquale, K\\xc3\\xa9vin Baranger, Santiago River. MT5-MMP promotes neuroinflammation, neuronal excitability and A\\xce\\xb2 production in primary neuron/astrocyte cultures from the 5xFAD mouse model of Alzheimer's disease. Journal of neuroinflammation vol 19 issue 1 2022 35277173 membrane-type matrix metalloproteinase 5 (mt5-mmp) deficiency in the 5xfad mouse model of alzheimer's disease (ad) reduces brain neuroinflammation and amyloidosis, and prevents deficits in synaptic activity and cognition in prodromal stages of the disease. 2022-03-12 2022-04-14 Not clear
Bridget Martinez, Philip V Peplo. Biomaterial and tissue-engineering strategies for the treatment of brain neurodegeneration. Neural regeneration research vol 17 issue 10 2022 35259816 further studies with in vivo models of alzheimer's disease and parkinson's disease are warranted especially using transplantation of cells in agarose micro-columns with an inner lumen filled with an appropriate extracellular matrix material. 2022-03-09 2022-04-14 Not clear
Christophe Cl\\xc3\\xa9ment Rey, Vincent Robert, Guillaume Bouisset, Ma\\xc3\\xafth\\xc3\\xa9 Loisy, S\\xc3\\xa9bastien Lopez, Vanessa Cattaud, Camille Lejards, Rebecca Ann Piskorowski, Claire Rampon, Vivien Chevaleyre, Laure Verre. Altered inhibitory function in hippocampal CA2 contributes in social memory deficits in Alzheimer's mouse model. iScience vol 25 issue 3 2022 35243253 parvalbumin (pv)-expressing interneurons which are often associated with the specific extracellular matrix perineuronal net (pnn) play a critical role in the alteration of brain activity and memory performance in alzheimer's disease (ad). 2022-03-04 2022-03-06 Not clear
Ivan Zaletel, Katarina Milutinovi\\xc4\\x87, Milo\\xc5\\xa1 Baj\\xc4\\x8deti\\xc4\\x87, Richard S Nowakowsk. Differentiation of Amyloid Plaques Between Alzheimer's Disease and Non-Alzheimer's Disease Individuals Based on Gray-Level Co-occurrence Matrix Texture Analysis. Microscopy and microanalysis : the official journal of Microscopy Society of America, Microbeam Analysis Society, Microscopical Society of Canada vol 27 issue 5 2022 35105417 differentiation of amyloid plaques between alzheimer's disease and non-alzheimer's disease individuals based on gray-level co-occurrence matrix texture analysis. 2022-02-02 2022-02-06 Not clear
Charis Ringland, Jonas Elias Schweig, Maxwell Eisenbaum, Daniel Paris, Ghania Ait-Ghezala, Michael Mullan, Fiona Crawford, Laila Abdullah, Corbin Bachmeie. MMP9 modulation improves specific neurobehavioral deficits in a mouse model of Alzheimer's disease. BMC neuroscience vol 22 issue 1 2021 34034683 matrix metallopeptidase 9 (mmp9) has been implicated in a variety of neurological disorders, including alzheimer's disease (ad), where mmp9 levels are elevated in the brain and cerebrovasculature. 2022-02-01 2022-01-13 Not clear
Pamela V Martino Adami, Adelina Orellana, Pablo Garc\\xc3\\xada, Luca Kleineidam, Emilio Alarc\\xc3\\xb3n-Mart\\xc3\\xadn, Laura Montrreal, Nuria Aguilera, Ana Espinosa, Carla Abdelnour, Maitee Rosende-Roca, Juan Pablo Tartari, Liliana Vargas, Ana Maule\\xc3\\xb3n, Ester Esteban-De Antonio, Rogelio L\\xc3\\xb3pez-Cuevas, Maria Carolina Dalmasso, Rafael Campos Martin, Kayenat Parveen, Victor M Andrade Fuentes, Najaf Amin, Shahzad Ahmad, M Arfan Ikram, Piotr Lewczuk, Johannes Kornhuber, Oliver Peters, Lutz Fr\\xc3\\xb6lich, Eckart R\\xc3\\xbcther, Jens Wiltfang, Lluis Tarraga, Merce Boada, Wolfgang Maier, Itziar de Rojas, Amanda Cano, Angela Sanabria, Montserrat Alegret, Isabel Hern\\xc3\\xa1ndez, Marta Marqui\\xc3\\xa9, Sergi Valero, Cornelia M van Duijn, Michael Wagner, Frank Jessen, Anja Schneider, Mar\\xc3\\xada Eugenia S\\xc3\\xa1ez Go\\xc3\\xb1i, Antonio Gonz\\xc3\\xa1lez P\\xc3\\xa9rez, Agust\\xc3\\xadn Ruiz, Alfredo Ram\\xc3\\xadre. Matrix metalloproteinase 10 is linked to the risk of progression to dementia of the Alzheimer's type. Brain : a journal of neurology vol issue 2022 35088840 matrix metalloproteinase 10 is linked to the risk of progression to dementia of the alzheimer's type. 2022-01-28 2022-02-06 Not clear
Pamela V Martino Adami, Adelina Orellana, Pablo Garc\\xc3\\xada, Luca Kleineidam, Emilio Alarc\\xc3\\xb3n-Mart\\xc3\\xadn, Laura Montrreal, Nuria Aguilera, Ana Espinosa, Carla Abdelnour, Maitee Rosende-Roca, Juan Pablo Tartari, Liliana Vargas, Ana Maule\\xc3\\xb3n, Ester Esteban-De Antonio, Rogelio L\\xc3\\xb3pez-Cuevas, Maria Carolina Dalmasso, Rafael Campos Martin, Kayenat Parveen, Victor M Andrade Fuentes, Najaf Amin, Shahzad Ahmad, M Arfan Ikram, Piotr Lewczuk, Johannes Kornhuber, Oliver Peters, Lutz Fr\\xc3\\xb6lich, Eckart R\\xc3\\xbcther, Jens Wiltfang, Lluis Tarraga, Merce Boada, Wolfgang Maier, Itziar de Rojas, Amanda Cano, Angela Sanabria, Montserrat Alegret, Isabel Hern\\xc3\\xa1ndez, Marta Marqui\\xc3\\xa9, Sergi Valero, Cornelia M van Duijn, Michael Wagner, Frank Jessen, Anja Schneider, Mar\\xc3\\xada Eugenia S\\xc3\\xa1ez Go\\xc3\\xb1i, Antonio Gonz\\xc3\\xa1lez P\\xc3\\xa9rez, Agust\\xc3\\xadn Ruiz, Alfredo Ram\\xc3\\xadre. Matrix metalloproteinase 10 is linked to the risk of progression to dementia of the Alzheimer's type. Brain : a journal of neurology vol issue 2022 35088840 mild cognitive impairment subjects with increased csf level of matrix metalloproteinase 10 showed a higher probability of progressing to dementia of the alzheimer's type and a faster cognitive decline. 2022-01-28 2022-02-06 Not clear
Pamela V Martino Adami, Adelina Orellana, Pablo Garc\\xc3\\xada, Luca Kleineidam, Emilio Alarc\\xc3\\xb3n-Mart\\xc3\\xadn, Laura Montrreal, Nuria Aguilera, Ana Espinosa, Carla Abdelnour, Maitee Rosende-Roca, Juan Pablo Tartari, Liliana Vargas, Ana Maule\\xc3\\xb3n, Ester Esteban-De Antonio, Rogelio L\\xc3\\xb3pez-Cuevas, Maria Carolina Dalmasso, Rafael Campos Martin, Kayenat Parveen, Victor M Andrade Fuentes, Najaf Amin, Shahzad Ahmad, M Arfan Ikram, Piotr Lewczuk, Johannes Kornhuber, Oliver Peters, Lutz Fr\\xc3\\xb6lich, Eckart R\\xc3\\xbcther, Jens Wiltfang, Lluis Tarraga, Merce Boada, Wolfgang Maier, Itziar de Rojas, Amanda Cano, Angela Sanabria, Montserrat Alegret, Isabel Hern\\xc3\\xa1ndez, Marta Marqui\\xc3\\xa9, Sergi Valero, Cornelia M van Duijn, Michael Wagner, Frank Jessen, Anja Schneider, Mar\\xc3\\xada Eugenia S\\xc3\\xa1ez Go\\xc3\\xb1i, Antonio Gonz\\xc3\\xa1lez P\\xc3\\xa9rez, Agust\\xc3\\xadn Ruiz, Alfredo Ram\\xc3\\xadre. Matrix metalloproteinase 10 is linked to the risk of progression to dementia of the Alzheimer's type. Brain : a journal of neurology vol issue 2022 35088840 csf matrix metalloproteinase 10 increased the prediction accuracy of csf a\xce\xb242, p-tau181, and t-tau for conversion to dementia of the alzheimer's type. 2022-01-28 2022-02-06 Not clear
Pamela V Martino Adami, Adelina Orellana, Pablo Garc\\xc3\\xada, Luca Kleineidam, Emilio Alarc\\xc3\\xb3n-Mart\\xc3\\xadn, Laura Montrreal, Nuria Aguilera, Ana Espinosa, Carla Abdelnour, Maitee Rosende-Roca, Juan Pablo Tartari, Liliana Vargas, Ana Maule\\xc3\\xb3n, Ester Esteban-De Antonio, Rogelio L\\xc3\\xb3pez-Cuevas, Maria Carolina Dalmasso, Rafael Campos Martin, Kayenat Parveen, Victor M Andrade Fuentes, Najaf Amin, Shahzad Ahmad, M Arfan Ikram, Piotr Lewczuk, Johannes Kornhuber, Oliver Peters, Lutz Fr\\xc3\\xb6lich, Eckart R\\xc3\\xbcther, Jens Wiltfang, Lluis Tarraga, Merce Boada, Wolfgang Maier, Itziar de Rojas, Amanda Cano, Angela Sanabria, Montserrat Alegret, Isabel Hern\\xc3\\xa1ndez, Marta Marqui\\xc3\\xa9, Sergi Valero, Cornelia M van Duijn, Michael Wagner, Frank Jessen, Anja Schneider, Mar\\xc3\\xada Eugenia S\\xc3\\xa1ez Go\\xc3\\xb1i, Antonio Gonz\\xc3\\xa1lez P\\xc3\\xa9rez, Agust\\xc3\\xadn Ruiz, Alfredo Ram\\xc3\\xadre. Matrix metalloproteinase 10 is linked to the risk of progression to dementia of the Alzheimer's type. Brain : a journal of neurology vol issue 2022 35088840 our findings support the use of csf matrix metalloproteinase 10 as a prognostic marker for dementia of the alzheimer's type and its inclusion to the [a/t/(n)] scheme to incorporate pathologic aspects beyond amyloid and tau. 2022-01-28 2022-02-06 Not clear
Yanwen Chen, Dejun Hu, Lisha Zhao, Weiwei Tang, Bin L. Unraveling metabolic alterations in transgenic mouse model of Alzheimer's disease using MALDI MS imaging with 4-aminocinnoline-3-carboxamide matrix. Analytica chimica acta vol 1192 issue 2022 35057932 unraveling metabolic alterations in transgenic mouse model of alzheimer's disease using maldi ms imaging with 4-aminocinnoline-3-carboxamide matrix. 2022-01-21 2022-01-27 Not clear
Wojciech Michno, Patrick M Wehrli, Srinivas Koutarapu, Christian Marsching, Karolina Minta, Junyue Ge, Sven W Meyer, Henrik Zetterberg, Kaj Blennow, Corinna Henkel, Janina Oetjen, Carsten Hopf, J\\xc3\\xb6rg Hanriede. Structural Amyloid Plaque Polymorphism is Associated with Distinct Lipid Accumulations Revealed by Trapped Ion Mobility Mass Spectrometry Imaging (TIMS MSI). Journal of neurochemistry vol issue 2021 34882796 herein, we used matrix assisted laser desorption/ionization mass spectrometry imaging (maldi-msi) trapped ion mobility spectrometry time-of-flight (tims tof) in combination with hyperspectral confocal microscopy to probe the lipidomic microenvironment associated with structural polymorphism of a\xce\xb2 plaques in transgenic alzheimer's disease mice (tgapp 2021-12-09 2022-01-13 Not clear
Rohmad Yudi Utomo, Yasunobu Asawa, Satoshi Okada, Hyun Seung Ban, Atsushi Yoshimori, J\\xc3\\xbcrgen Bajorath, Hiroyuki Nakamur. Development of curcumin-based amyloid \\xce\\xb2 aggregation inhibitors for Alzheimer's disease using the SAR matrix approach. Bioorganic & medicinal chemistry vol 46 issue 2021 34391121 development of curcumin-based amyloid \xce\xb2 aggregation inhibitors for alzheimer's disease using the sar matrix approach. 2021-11-15 2022-01-13 Not clear
Yeonwoo Chung, Hyunju Le. Correlation between Alzheimer's disease and type 2 diabetes using non-negative matrix factorization. Scientific reports vol 11 issue 1 2021 34315930 correlation between alzheimer's disease and type 2 diabetes using non-negative matrix factorization. 2021-11-08 2022-01-13 Not clear
Kai Wei, Wei Kong, Shuaiqun Wan. Associating brain imaging phenotypes and genetic in Alzheimer's disease via JSCCA approach with autocorrelation constraints. Medical & biological engineering & computing vol issue 2021 34714488 to improve the performance and interpretability of scca, we proposed a penalty method based on the autocorrelation matrix for discovering the possible biological mechanism between single nucleotide polymorphisms (snp) variations and brain regions changes of alzheimer's disease (ad). 2021-10-29 2022-01-13 Not clear
Dongmei Gu, Fang Liu, Meng Meng, Liling Zhang, Marc L Gordon, Ying Wang, Li Cai, Nan Zhan. Elevated matrix metalloproteinase-9 levels in neuronal extracellular vesicles in Alzheimer's disease. Annals of clinical and translational neurology vol 7 issue 9 2021 32790155 elevated matrix metalloproteinase-9 levels in neuronal extracellular vesicles in alzheimer's disease. 2021-10-18 2022-01-13 Not clear
Dongmei Gu, Fang Liu, Meng Meng, Liling Zhang, Marc L Gordon, Ying Wang, Li Cai, Nan Zhan. Elevated matrix metalloproteinase-9 levels in neuronal extracellular vesicles in Alzheimer's disease. Annals of clinical and translational neurology vol 7 issue 9 2021 32790155 this study aimed to investigate plasma neuronally derived extracellular vesicle (ndev) levels of core pathological markers [amyloid-\xce\xb2 (a\xce\xb2) and phosphorylated tau] and inflammatory biomarkers, including interleukin 6 (il-6) and matrix metalloproteinase-9 (mmp-9) in patients with alzheimer's disease (ad). 2021-10-18 2022-01-13 Not clear
Charis Ringland, Jonas Elias Schweig, Maxwell Eisenbaum, Daniel Paris, Ghania Ait-Ghezala, Michael Mullan, Fiona Crawford, Laila Abdullah, Corbin Bachmeie. MMP9 modulation improves specific neurobehavioral deficits in a mouse model of Alzheimer's disease. BMC neuroscience vol 22 issue 1 2021 34034683 matrix metallopeptidase 9 (mmp9) has been implicated in a variety of neurological disorders, including alzheimer's disease (ad), where mmp9 levels are elevated in the brain and cerebrovasculature. 2021-10-11 2022-01-13 Not clear
Chunlei Zheng, Rong X. Molecular subtyping of Alzheimer's disease with consensus non-negative matrix factorization. PloS one vol 16 issue 5 2021 34014928 molecular subtyping of alzheimer's disease with consensus non-negative matrix factorization. 2021-10-06 2022-01-13 Not clear
Page: 
1   2   3   4   5   6   7   8   9   10   11